171 related articles for article (PubMed ID: 27861291)
21. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
Sinkovics JG
Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
[TBL] [Abstract][Full Text] [Related]
22. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
23. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
[TBL] [Abstract][Full Text] [Related]
24. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice.
van Rijn RS; Simonetti ER; Hagenbeek A; Hogenes MC; de Weger RA; Canninga-van Dijk MR; Weijer K; Spits H; Storm G; van Bloois L; Rijkers G; Martens AC; Ebeling SB
Blood; 2003 Oct; 102(7):2522-31. PubMed ID: 12791667
[TBL] [Abstract][Full Text] [Related]
25. Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28.
Poirier N; Mary C; Le Bas-Bernardet S; Daguin V; Belarif L; Chevalier M; Hervouet J; Minault D; Ville S; Charpy V; Blancho G; Vanhove B
MAbs; 2014; 6(3):697-707. PubMed ID: 24598534
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
[TBL] [Abstract][Full Text] [Related]
27. Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease.
Michael M; Shimoni A; Nagler A
Isr Med Assoc J; 2013 Jan; 15(1):44-50. PubMed ID: 23484241
[TBL] [Abstract][Full Text] [Related]
28. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
[TBL] [Abstract][Full Text] [Related]
29. Alloanergization Method for Inducing Allospecific Hyporesponsiveness in PBMC Exposed to Allostimulation In Vitro in the Context of Costimulatory Molecule Blockade.
Barbon CM; Janec KJ; Kelner RH; Norton JE; Guinan EC
Methods Mol Biol; 2019; 1899():103-118. PubMed ID: 30649768
[TBL] [Abstract][Full Text] [Related]
30. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
[TBL] [Abstract][Full Text] [Related]
31. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease.
Bruck F; Belle L; Lechanteur C; de Leval L; Hannon M; Dubois S; Castermans E; Humblet-Baron S; Rahmouni S; Beguin Y; Briquet A; Baron F
Cytotherapy; 2013 Mar; 15(3):267-79. PubMed ID: 23265769
[TBL] [Abstract][Full Text] [Related]
32. Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody.
Hatano R; Ohnuma K; Yamamoto J; Dang NH; Yamada T; Morimoto C
Br J Haematol; 2013 Jul; 162(2):263-77. PubMed ID: 23692598
[TBL] [Abstract][Full Text] [Related]
33. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
Saito K; Sakurai J; Ohata J; Kohsaka T; Hashimoto H; Okumura K; Abe R; Azuma M
J Immunol; 1998 May; 160(9):4225-31. PubMed ID: 9574523
[TBL] [Abstract][Full Text] [Related]
34. Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-/-γc-/- mouse model.
Hogenes MC; van Dorp S; van Kuik J; Monteiro FR; ter Hoeve N; van Dijk MR; Martens AC; de Weger RA
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1023-35. PubMed ID: 22579931
[TBL] [Abstract][Full Text] [Related]
35. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.
King MA; Covassin L; Brehm MA; Racki W; Pearson T; Leif J; Laning J; Fodor W; Foreman O; Burzenski L; Chase TH; Gott B; Rossini AA; Bortell R; Shultz LD; Greiner DL
Clin Exp Immunol; 2009 Jul; 157(1):104-18. PubMed ID: 19659776
[TBL] [Abstract][Full Text] [Related]
36. Graft-versus-Host Disease in a Dog After Reduced-intensity Hematopoietic Stem Cell Transplantation from a DLA-identical Littermate.
Schaefer S; Werner J; Lange S; Machka C; Knuebel G; Sekora A; Roolf C; Winkler T; Murua Escobar H; Nolte I; Junghanss C
In Vivo; 2016; 30(4):427-32. PubMed ID: 27381604
[TBL] [Abstract][Full Text] [Related]
37. Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice.
Buchele V; Büttner-Herold M; Vogler T; Neurath MF; Hildner K
J Vis Exp; 2019 Feb; (144):. PubMed ID: 30799849
[TBL] [Abstract][Full Text] [Related]
38. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
[TBL] [Abstract][Full Text] [Related]
39. Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.
Ville S; Poirier N; Branchereau J; Charpy V; Pengam S; Nerriere-Daguin V; Le Bas-Bernardet S; Coulon F; Mary C; Chenouard A; Hervouet J; Minault D; Nedellec S; Renaudin K; Vanhove B; Blancho G
J Am Soc Nephrol; 2016 Dec; 27(12):3577-3588. PubMed ID: 27160407
[TBL] [Abstract][Full Text] [Related]
40. Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants.
Herretes S; Ross DB; Duffort S; Barreras H; Yaohong T; Saeed AM; Murillo JC; Komanduri KV; Levy RB; Perez VL
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2348-57. PubMed ID: 25655798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
